Rulonilimab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Rulonilimab, covering 2023-02-24 to 2025-01-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer [Phase 2, Phase 3]